Guardant Health, Inc. (GH) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

would like to ask a question, please press star 1 on your telephone keypad. I would now like to pass the conference over to your host, Zarek Khurshid, VP of Investor Relations. You may proceed. Zarek Khurshid, VP of Investor Relations Thank you. Earlier today, Garden Health released financial results for the quarter and year ended December 31, 2024. Joining me today from GARDEN are Hal Neal Tukey, Co-CEO, Amir Ali Talasaz, Co-CEO, and Mike Bell, Chief Financial Officer. Before we begin, I'd like to remind you that during this call, management will be making forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. This call will also include a discussion of non-GAAP financial measures, which are adjusted to exclude certain specified items. Additional information regarding material risks and uncertainties, as well as the non-GAAP financial reconciliation to most directly comparable GAAP financial measures, are available in the press release GARDEN issued today, as well as in our 10-K and other filings with the SEC. GARDEN disclaims any intention or obligation to update or revise financial projections and forward-looking statements, whether because of new information, future events, or otherwise, except as required by law. The information in this conference call is accurate only as of the live broadcast. With that, I'd like to turn the call over to Halmy. Thanks, Eric. Good afternoon, and thank you for joining our fourth quarter and full year 2024 earnings call. Starting on slide three, 2024 was an outstanding year for Garden. I'm so proud of our team for their hard work and execution on delivering on a number ...